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Abstract 
Many bacteria have become resistant to commonly used antibiotics because of antibiotic use 
in people and animals. Therefore, new antibiotics are needed that will inhibit these resistant 
bacteria. Bacteria found in soil are a likely source for new antibiotics because of the limited 
available nutrients found in the soil. We isolated soil bacteria and screened them for 
antibiotic production against Staphylococcus epiderm/dis. Methanol extracts were made 
from entire agar plates of the soil bacteria that inhibited S. epiderm/dis. These extracts were 
spotted on a lawn of Staphylococcus aureus; growth inhibition was measured to confirm that 
the extracts contained the antimicrobial compounds. The confirmed inhibitory extracts were 
then separated by thin-layer chromatography using a chloroform-methanol mobile phase. 
The separated compounds were individually suspended in methanol and spotted onto 
S. epiderm/dis or S. aureus to assess inhibitory ability. Whole cell metabolite extracts isolated 
from four soil bacteria were found to inhibit both S. epiderm/dis and S. aureus. Four TLC-
separated metabolite compounds, one from Hargis and three from Jackson, were found to 
inhibit S. epiderm/dis. These compounds will be further assessed for viability as new 
therapeutically relevant antibiotic treatments. 
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INTRODUCTION 
Antibiotics production has been observed in a variety of bacterial species. An antibiotic is any 
molecule that inhibits the growth of or kills a microorganism. Antibiotics are most often produced in 
response to nutrient limitation. Bacteria manufacture these molecules as a competition mechanism, 
inhibiting nearby microorganisms that may be consuming necessary and limited resources (Hibbing, 
Fuqua, Parsek, & Peterson, 2010). A bacterium has no way of "seeing" if its neighbors are consuming the 
resources. So instead, when a major nutrient is limited, bacteria go into the stationary phase of growth 
and begin to produce secondary metabolites, including antibiotics (Aharonowitz & Demain, 1978). This 
introduction into the stationary phase can be signaled by catabolite repression or the stringent 
response. In catabolite repression, the absence of glucose causes the production of cAMP, which 
functions as a signaling molecule to stimulate the production of a variety of secondary metabolites 
including antibiotics (Aharonowitz & Demain, 1978). In the stringent response, a lack of nitrogen and 
thus charged tRNA causes the production of guanosine tetra phosphate, which also can signal antibiotic 
production (Traxler et al., 2008). 
In addition to nutrient starvation, crowding can also stimulate antibiotic production. Quorum 
sensing is when bacteria perform an action only when the population has reached an elevated level 
(Waters & Bassler, 2005). Bacterial cells may produce an autoinducer that diffuses out of the cell. If 
there are enough cells of the same species producing this autoinducer, it will begin to diffuse back into 
the cells. The autoinducer will then signal for upregulation of various genes, including antibiotic 
synthesis genes (Waters & Bassler, 2005). When quorum sensing is used in antibiotic production, 
antibiotics are produced and stored so that lethal quantities can be released quickly to kill or inhibit the 
target cells without time for the cells to acquire resistance (Hibbing et al., 2010). 
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MECHANISMS OF ANTIBIOTIC RESISTANCE 
Examples of mechanisms of antlbloUc resistance 
Figure 1: Mechanisms of antibiotic resistance. 
~ ~~~ 
bacterial cell 
....,_tlon of drug target 
This figure shows the most common mechanisms of bacterial resistance against antibiotics. 
Mutations and acquisitions of adventitious physiological changes are common in bacteria because of 
their short generation time. When a population of bacteria is exposed to low levels of an antibiotic, 
resistance may develop as the individual cells that have a mutation protecting them from the antibiotic 
are able to survive and pass on the genes for that trait (Hibbing et al., 2010). Figure one indicates how 
bacteria can become resistant to antibiotics by decreasing production of porins that import the 
antibiotic, by producing efflux pumps to remove the antibiotic from within the cell, by producing an 
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enzyme to degrade or inactivate the antibiotic, or by acquiring mutations in the binding target of the 
antibiotic (Morier, 2016). 
Antibiotic resistance in pathogenic bacteria is a huge problem in the medical field. Every year, in the 
United States alone, more than 2 million people become infected with bacteria that are resistant to at 
least one commonly used antibiotic ("Antibiotic Resistance", 2013). Figure two illustrates that 
methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and fluoroquinolone-
resistant Pseudomonas aeruginosa have been on the rise since the early 1980s, only 40 years after the 
first antibiotic, penicillin, was produced for commercial use ("Alexander Fleming", 1999). Widespread 
resistance to penicillin and similar P-lactams such as methicillin is now a large problem because of 
overuse of these early antibiotics. Many bacteria were exposed to the antibiotic and resistant strains 
survived and proliferated, causing population growth of the resistant strains. Exposure to antibiotics 
may come through human ingestion and passage to waste water or through animal prescriptions 
("Antibiotic use", 2014) (Rizzo et al., 2013). 
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enterococci, FQRP = fluoroquinolone-resistant Pseudomonas aeruginosa 
Infectious Diseases Society ol America. 2004. Bad Bugs, No Drugs. 
Figure 2: Rise of antibiotic-resistant bacteria since 1980. This graph shows three antibiotic 
resistant bacteria and the increase in percent incidence over the past 35 years. 
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Mass production and funding for research for the discovery of new antibiotics has been slowing 
down, even as bacterial resistance has been on the rise. Many drug companies have stopped producing 
antibiotics, because of the poor financial investment return. The problem is that antibiotics do their job. 
They kill the bacteria, stop the infection, and are no longer needed. Drug companies are more interested 
in drugs for long-term use and chronic illnesses ("Race against time", 2011). These drugs will continue to 
sell because they are required for the rest of a patient's life. Another problem affecting production of 
new antibiotics is lack of novelty in antibiotic mechanism. The World Health Organization reports that in 
a 2008 study, only 15 of 167 antibiotics being researched displayed potential to combat multidrug 
resistant pathogens ("Race against time", 2011). 
In light of the increase of antibiotic resistant bacteria and decreasing number of effective 
commercial antibiotics, new antibiotic discovery is imperative. In this project I screened soil bacteria for 
antibiotic production. Once antibiotic producers were identified, I used two-Bubbles and Hargis-- as 
models to optimize antimicrobial extraction and purification methods. I then assayed whole cell extracts 
and isolated compounds for activity against Staphylococcus. 
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A Need for New Antibiotics 
Acquisition of antibiotic resistance in bacteria found in livestock: 
Antibiotic resistance in pathogenic bacteria is an increasingly important problem in the medical 
field over the past few decades. In 2014 the Centers for Disease Control and Prevention (CDC) stated 
that an estimated 2 million people per year become infected with antibiotic resistant bacteria and at 
least 23,000 people die each year due to these infections (Antibiotic Resistance, 2014). These pathogens 
become resistant when they are repeatedly exposed to the antibiotic through human or animal use. The 
bacteria can defend itself against antibiotics by a variety of traits including diminished production of 
porins, increased production of efflux pumps, inactivation or destruction of the antibiotic, or mutat ion 
of the binding target. Once any one of these traits is acquired, the susceptible bacteria which are 
exposed to the antibiotic quickly die, leaving the resistant ones alive and thriving, often without other 
bacteria to compete with for a food source. 
IS A c 
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Figure 3: Spread of Antibiotic Resistant Bacteria from Livestock. 
Antibiotic use in livestock can select for resistant bacteria that can then be spread to humans via 
meats, animal products, and vegetables. This image was published by the CDC. 
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When animals are fed antibiotics, resistant bacteria survive and reproduce, permitting livestock 
to act as a reservoir for antibiotic resistant bacteria (NARMS, 2015). While it is difficult to directly 
compare the amount of antibiotics being used in livestock and in humans, several studies have indicated 
that about 75% of antibiotics sold in the US are sold into the livestock industry (2013 Summary, 2015). 
While this antibiotic usage in livestock arguably helps animals and farmers, it contributes to the rise of 
antibiotic resistant bacterial infections in humans. 
Estimated Annual Antibiotic Use in the United States 
70,000 kg 
150,000 kg l l 150.000 kg 
• Livestock • Humans • Aquaculture Crops • Pets 
Figure 4: Distribution of Antibiotic Use per Year. 
This graph shows the estimated percentage of antibiotics used per year in 
ki lograms for livestock, humans, aquaculture, crops, and pets. This image 
was produced by Aidan Hollis and published in The New England Journal 
of Medicine. 
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Transmission of resistant bacteria from livestock to humans: 
The resistant bacteria cultured in antibiotic-treated animals can be passed to humans in one of 
three ways: consumption of undercooked meat, consumption of crops grown in manure fertilizer, and 
water runoff from farms and agricultural environments (NARMS, 2015). Many intensively farmed food 
animals, such as chickens and turkeys, are routinely fed antibiotics during growth. The consequent 
resistant bacteria can be transmitted to humans if the meat is not cooked properly. Further, fertilizers 
made with animal fecal matter can contain the resistant bacteria and contaminate fields of fruits and 
vegetables. Water runoff from agricultural environments, like livestock ranches and farms, can contain 
the. resistant bacteria as well (Fig. 5)(NARMS, 2015). An example of a bacteria transmitted in this way is 
Salmonella, which causes an estimated 1.2 million infections in the United States each year. Of these, 
about 23,000 are hospitalized, and 450 die from their infections (NARMS, 2015). It is very important that 
pathogenic bacteria like these are exposed to the least amount of ant ibiotics possible to reduce 
proliferation of resistant strains. 
Antibiotic resistant bacteria can also be passed from person to person. People carrying these 
bacteria can transmit the infection through everyday contact in social environments. Some of the places 
bacteria are most likely to spread are medical environments like hospitals and nursing homes (Fig. 6). 
NTIBIOTIC R s I TA CE 
----,~~ from the farm to the table 
SPREAD Resistant bacteria can spread to ... 
-
Figure 5: Spread of Antibiotic Resistant Bacteria to Humans. 
Bacteria can be transferred to humans when we eat animal products or products that have 
been contaminated by bacteria in the environment, soil, or water. Published by the CDC. 
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Misuse of antibiotics and promotion of livestock growth: 
Resistant bacteria result from widespread, repeated use of antibiotics. These drugs are not just 
used to treat sick animals in the agriculture industry. Antibiotics are often used fed to animals that live 
in close quarters to keep them healthy and to promote their growth (Fig. 6). Antibiotic use has been 
shown to increase animal growth by inhibiting the normal gut flora, which allows the animal to better 
utilize nutrients, as there are less microbes to consume the nutrients (Gaskins, Collier, & Anderson, 
2002). Since antibiotic-treated animals have fewer microbes in their gut, the animal is able to spend less 
energy maintaining the balance of gut flora, which also increases the size ofthe animal (Gaskins et al., 
2002). The development of antibiotic resistance in bacteria has been expedited by the concurrent use of 
similar antibiotic in humans and animals. Figure 6 shows antibiotic classes prescribed to animals. All 
antibiotic classes used in livestock are also prescribed to humans except ionophores. Bacteria that are 
resistant to one antibiotic are often also resistant to other antibiotics that work by a similar mechanism. 
Therefore, the use of antibiotics with similar mechanisms in humans and animals increases the potential 
for resistance development (Fig. 6). 
Antibiotic Use by Class 
• Aminoglycosides • Cephalosporins 
• Fluoroquinolones • lonophores 
• Lincosamides • Macrolides 
• Penicillins • Sulfas 
• Tetracyclines • Not Reported 
Jl ~Antibiotic Use by Mechanism of 
Action 
• Wall Synthesis • Membrane Transport 
• Ribosome Binding • DNA Gyrase 
• Enzyme Inhibitions • Not Reported 
Figure 6: Antibiotic drug classes currently used in the treatment of livestock in kilograms. 
Bacteria that acquire resistance to one antibiotic often also have resistance to antibiotics that work through the 
same or similar mechanisms. Chart 6A shows different classes of antibiotics used in livestock. Chart 6B shows 
antibiotics separated by mechanism. Charts adapted from information published in the "2013 FDA Annual Report on 
Antimicrobial Sold or Distributed for Use in Food-Producing Animals." 
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Figure 7: Spread of antibiotic resistant bacteria among animals and humans. 
Bacteria that are resistant to antibiotics can be spread from animals to people. From there 
these bacteria can be spread through everyday contact or through healthcare facilities like 
hospitals and nursing homes. 
Changes being made to decrease resistance in bacteria carried by livestock: 
The Generic Animal Drug and Patent Restoration Act (GADPTRA), passed in November of 1988, was 
one of the first laws that brought information about livestock-approved antibiotics into the public eye. 
This act requires information on all drugs approved by the Food and Drug Administration (FDA) for use 
in the treatment of animals to be made available to the public in a publication known as the Green Book 
(Green Book, 2016). The Green Book contains information on drug trade names, active ingredients, 
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sponsor companies, and species it has been approved for use on (Green Book, 2016). The information 
made available in the Green Book aids scientists in their research on antibiotic resistant bacteria. 
The National Antimicrobial Resistance Monitoring System (NARMS) is a collaboration of the CDC, 
FDA, and the U.S. Department of Agriculture (USDA) that was launched in 1996. This system tracks 
antibiotic resistant bacteria, such as Salmonella and Campylobacter, which are known to infect humans 
through food (NARMS, 2015). The system also identifies control points that can reduce the transfer of 
antibiotic resistant bacteria to food, soil, and water from agricultural locations. NARMS tests humans, 
livestock, and retail meat for resistant bacterial strains to monitor trends and out breaks, helping them 
better understand the emergence and spread of antibiotic resistance. NARMS also provides information 
to federal agencies, policymakers, agricultural industries, and the public on how to reduce resistance 
among bacteria in food-producing animals and helps the FDA make decisions regarding safe ant ibiotic 
use for animals (NARMS, 2015). One of NARMS primary recommendations is that antibiotics be used 
only for therapeutic purposes and that they be reserved for treatment of animal and human health 
needs and only under the supervision of a qualified health professional (NARMS, 2015). 
Animal producing industries are getting pressure to moderate antibiotic use both from regulatory 
agencies and consumers. The increase in antibiotic resistant bacterial infections has made consumers 
more aware of the dangers of misusing antibiotics. Many food service companies are letting concerns 
about antibiotic resistance drive their purchase of meats. According to a report published in 2012, sales 
for meats without routine use of antibiotics were up 25 percent over the three prior years, despite an 
overall decline in U.S. per capita meat consumption of beef, pork, chicken and turkey over the same time 
period (Perrone, 2012). 
In addition to these consumer concerns and a growing demand for safer animal products, on April 
11th, 2012 the FDA published three documents that ca lled for steps to reduce antibiotic use in livestock 
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(US Food and Drug, 2012). The Judicious Use of Medically Important Antimicrobial Drugs in Food-
Producing Animals is a guide for the agricultural industry that recommends phasing out use of medically 
important drugs for promotion of livestock growth and phasing in veterinary oversight in the use of these 
antibiotics for therapeutic purposes. A draft guidance was also published which requested that drug 
companies voluntarily remove production uses of antibiotics from their FDA-approved product labels and 
add veterinary oversight to the marketing status. The final document released by the FDA on the topic 
was an outline of ways that veterinarians can authorize the use of certain animal drugs in feed, which 
can make the needed veterinary oversight efficient and practical (US Food and Drug, 2012). 
Due to this pressure from both the FDA and consumers, companies like McDonalds have promised 
to decrease the use of unnecessary antibiotics in their food-producing animals. McDonalds has a plan to 
completely eliminate the use of antibiotics important to human medicine from their chickens by March 
of 2017 (McDonalds, 2015). Panera Bread chicken and turkey products are both 100% antibiotic free as 
of 2015 (Yohannan, 2015). This trend continues to rise as many restaurant chains vow to use antibiotic-
free meat products. Cable Network News (CNN) has published a list of food service companies who are 
making changes in their policies on meats raised with antibiotics. The list reports that Panera Bread and 
Chipotle's are doing the best, serving almost all of their meats raised without routine antibiotic use 
Tinker, 2015). Chick-Fil-A is also making changes to their meats in regard to antibiotic use. Dunkin' 
Donuts and McDonald's are planning to make changes, but as of yet do not have working policies fully in 
place (Tinker, 2015). 
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MATERIALS AND METHODS 
Bacteria and Media: 
Bacteria. Hargis, Jackson, and Small are antibiotic-producing bacteria that were isolated at Ouachita 
Baptist University in Fall 2014. Additional bacteria were isolated from soil during this research as 
described in the Small World Initiative protocols (Data Collection, 2015). Staphylococcus epidermidis and 
Staphylococcus aureus were used as screening bacteria to assess the antibacterial efficacy of antibiotic-
producing soil bacteria and cell extracts. 
Media. All streak plates and spread-patch assays were performed on potato dextrose agar (PDA) 
plates. Most broths used were 100% brain heart infusion (BHI) broths. Hargis bacterium was grown in 
Luria-Bertani (LB) broth. 
Isolation of Soil Bacteria: 
Isolating Bacteria from Soil Sample. The purpose of 
plating the soil sample is to grow isolated bacterial colonies 
from the soil. Three grams of soil were diluted with 
phosphate buffered saline (PBS) to 30ml and mixed to form 
the 10"1 dilution. One milliliter of supernatant was taken 
from the 10"1 dilution and diluted with PBS to 15ml and 
mixed to form the 10-2 dilution. One hundred microliters of 
the 10-2 dilution were added to 9001J.L of PBS to make the 
10-3 dilution. This process was repeated to create dilutions 
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Figure 8: Quad-streak plate method 
Four different soil bacteria can be isolated on a 
quartered agar plate using this method. 
to 10"8• One hundred microliters of each dilution was spread evenly with a sterilized spreading rod onto 
PDA plates. Plates were allowed to incubate inverted for 48hrs at 25°C. 
Quad-streak plate. The purpose of the streak plate is to produce increasingly isolated colonies, each 
grown from a single bacterium. An agar plate was divided into quarters and labeled for bacteria to be 
streaked. A flamed loop was used to pick an isolated colony and streak the bacteria back and forth onto 
the appropriate quadrant of the agar plate. The loop was again flamed and pulled through the center of 
the previous streak to collect some bacteria and in a continuous motion, a second streak was made. This 
process was repeated 2 more times to produce 4 streaks with increasingly isolated bacterial cells (Fig. 8). 
Screening for Antibiotic Production: 
Figure 9: Spread Patch of soil bacteria against S. 
epidermidis. 
Zones of inhibition can be seen around the 
patches marked G (Buttercup) and N (Blossom). 
Spread Patch Method. This method was 
adapted from the Small World Initiative (Small 
World Initiative, 2012). A 4x4 grid was drawn 
onto the bottom of an agar plate. Squares 
were labeled for isolated soil bacteria and 
spaced so that bacteria were diagonal to each 
other, with at least one space in between. A 
maximum of 6 soil bacteria were applied to 
each plate. This was to ensure that the zone of 
inhibition could be clearly seen and measured 
for each individual bacterium. A sterile Q-tip 
was dipped into a broth of Staphylococcus and wrung out by pressing all surfaces of the Q-tip firmly to 
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the side ofthe tube. The screening bacteria was spread onto the agar plate by streaking the Q-tip back 
and forth to cover the entire agar surface, then turning the plate 45° and re-streaking with the same Q-
tip. This process was repeated 3 times for maximum coverage of screening bacteria. The screening was 
allowed 3-5 minutes to dry onto the surface ofthe agar before soil bacteria was streaked on. This was to 
prevent the soil bacteria from running in the excess broth on the top of the agar. A flamed loop was 
used to pick an isolated colony of soil bacteria and then this bacteria was streaked into the center of the 
labeled square to form a patch, making each patch a uniform size. Spread-patch plates were allowed to 
grow at least 2 days at 25aC, then the zone of inhibition was measured (Fig. 9). 
Isolation of Antimicrobial Metabolites: 
Whole Cell Metabolite Extraction. This method was adapted from The Small World Initiative (Small 
World Initiative, 2012). The purpose of antibiotic extraction is to obtain maximal antibiotics produced by 
the bacteria for testing and thin-layer chromatography (TLC) separation. Two hundred microliters of 
inoculated broth, grown for 2 days, was spread onto an agar plate and allow to grow at 25°C for 2-4 
days. The inoculated agar plate was chopped into 1cm2 pieces and both the agar and the bacterial lawn 
from one quarter of the plate was transferred into each of four glass scintillation vials. Vials were frozen 
at -2oac for 24hrs to lyse cells and release all metabolites produced. Three milliliters of methanol was 
added to each vial of frozen agar and bacteria. The vials were shaken at 120 to 170 rotations per minute 
(rpm) at 37°C for 24hrs to allow organic solvent to extract soluble components from the bacterial lawn 
and agar. All liquids were transferred from each of the vials into one clean vial. Organic solvents were 
allowed to evaporate by directing a weak stream of air onto the surface of the liquid for 24 to 48 hours. 
Whole cell extracts were resuspended in 801J.L of methanol. 
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TLC Separation. Each resuspended extract was spotted onto a TLC plate using a capillary pipette, 
making a spot of about 0.5 em in diameter. This was repeated five times, for a total of 6 droplets applied 
to the same location on the TLC plate, to ensure that adequate extract had been added to the plate. The 
TLC plate was run in a mobile system of 62 parts chloroform to 35 parts methanol to 3 parts water. 
Plates were viewed under both long and short wave UV light for visualization of separation. 
Confirmation of Antibiotic Presence: 
Spot inhibition assay. Two types of spot inhibition assays were performed: whole cell extract spot 
inhibition assays and TLC plate spot inhibition assays. For the whole cell extract spot inhibition assays, 
1011L of resuspended whole cell extract was spotted onto a PDA plate and allowed to dry. This was 
repeated 3 times for a total of 301-ll of extract per spot. A mixture of 7mL of 1/2x PDA top agar and 
20011L of 2 day incubated 5. epidermidis broth was poured over the spotted, dry, PDA plate. Spot 
inhibition assay using 2 day incubated 5. aureus-inoculated 1/4x PDA top agar was also performed. 
Following a 48 hour incubation period, zones of inhibition were measured to determine antimicrobial 
activity. 
For the TLC plate spot inhibition assays, TLC plate spots were cut out and the silica containing the 
spot was removed from the plate and transferred into a microcentrifuge tube. Sixty microliters of 
methanol was added to resuspend separated extracts. Five repetitions of 1011L spots of this suspension 
were pipetted onto a PDA plate and allowed to dry, for a total of 50!-ll. Two day incubated 5. 
epidermidis-inoculated 1/2x PDA top agar was poured over the spotted, dry, PDA plate. Following a 48 
hour incubation period, zones of inhibition were measured to determine antimicrobial activity. 
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Chloramphenicol and ampicillin were used as positive controls in both the whole cell extract spot 
inhibition assay and the TLC plate spot inhibition assay of 5. epidermidis and 5. aureus. Methanol was 
used as a negative control for both spot inhibition assays. 
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RESULTS 
Spread Patch. I found six bacteria that inhibited growth of S. epidermidis; two of these six bacteria 
inhibited growth of S. aureus. Zones of inhibition for all isolated soil bacteria are reported in Figure 10. 
Of these antimicrobial-producing bacteria, I chose three that consistently produced clear zones of 
inhibition in the Staphylococcus and named them Buttercup, Blossom, and Bubbles (Fig. 10). 
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Figure 10: Zones of inhibition produced by soil bacteria against S. epidermidis and S. aureus. 
Zones of inhibition were calculated by subtracting the width of the soil bacteria patch from the 
width of the zone of inhibition, divided by two. This calculation gives the width of the distance 
from the soil bacteria patch to the edge of the zone of inhibition. 
Because Bubbles consistently produced larger and clearer zones of inhibition in both types of 
Staphylococcus, I chose this bacterium to perform the whole cell metabolite extraction (Fig.11). 
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Figure 11: Zones of inhibition indicating antimicrobial compounds secretion from 
soil bacteria. 
A. Bubbles inhibiting growth of S. epidermidis. 
B. Buttercup inhibiting growth of S. epidermidis 
Spot inhibition assay of Whole Cell Methanol Extract. In addition to Bubbles, three bacteria-
Hargis, Jackson, and Small-- were chosen for whole cell methanol extraction and their extracts were 
screened againt S. aureus and S. epidermidis (Fig. 12). Commercial antibiotics ampicillin and 
chloramphenicol were used as positive controls and substantially inhibited S. aureus growth (Fig. 12). 
Methanol was used as a negative control to be sure that the process of spotting methanol onto the agar 
and allowing it to dry was not creating some sort of inhibitory effect on the Staphylococcus. Whole cell 
extracts of Bubbles, Hargis, and Small all inhibited S. aureus (Fig. 12A). In a second whole cell extract 
spot inhibition assay, Jackson also inhibited S. aureus (Fig. 12B). Hargis showed the largest zone of 
inhibition, inhibiting the Staphylococcus in a large area around the applied droplet (Fig. 12A). The 
antimicrobial metabolite produced by Hargis seems to have diffused through the agar into the 
surrounding area. 
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Figure 12: Whole cell extract spot inhibition assay against S. 
au reus. 
Whole cell extract of Bubble, Hargis, Jackson, and Small plated 
against S. aureus in a spot inhibition assay. Jackson did not inhibit 
S. aureus in the first assay (Fig. 12A), but did show inhibition in 
subsequent assays (Fig. 12B). Ampicillin and chloramphenicol were 
used as positive controls. Methanol was used as a negative control. 
TLC Separation. Whole cell extracts of Bubbles, Hargis, Jackson, and Small were individually spotted 
onto a TLC plate and run in a chloroform/methanol mobile phase. Rt measurements were recorded for 
each separated spot. Figures 15 and 16 show the final R1 measurements from TLC plates separating 
whole cell extract from Bubbles, Hargis, Jackson, and Small. 
I tried two different methods of whole cell metabolite extraction of Bubbles and Hargis, one using 
methanol as described in the methods section and one using ethyl acetate and water (Small World 
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Initiative, 2012). The ethyl acetate method was supposed to yield an ethyl acetate layer containing 
extracted organic metabolites and a water layer containing cell debris. Unfortunately, with some 
bacteria, the ethyl acetate and water did not separate, producing an emulsion which contained both cell 
debris and extracted metabolites. Since cell debris made TLC separation more difficult, I chose to use the 
methanol extraction for the rest of my research. The first TLC plate of Hargis compares separation 
results using the methanol or ethyl acetate extraction methods (Fig. 13). 
Bubbles did not separate very well with either type of extraction, although fresh extracts separated 
better than old extracts (Fig. 14 and 15A). Many of the TLC spots were indistinct and difficult to 
separate. Some spots were only visible under short wave UV light and some were only visible under long 
wave UV light. Figures 13 through 15 show all TLC spots, regardless of viewing wavelength . 
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Figure 13: TLC Separation of whole cell 
Hargis ethyl acetate or methanol extract 
following growth in LB or BHI broth 
Hargis did not grow well in BHI broth and 
was grown in LB broth prior to plating. 
Ethyl acetate (ETAC) and methanol (MeOH) 
were compared as extraction solvents. 
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Figure 14: Old extract reduces separation in 
TLC. 
Old whole cell metabolite extract does not 
separate well on TLC plates. The extract 
becomes viscous and sticky. Fresh extract 
yields much better separation (Fig. 15). 
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Figure 15: Final TLC plates separating whole cell extracts of Bubbles, Hargis, Jackson, and Small. 
All four whole cell extracts were successfully separated by TLC and R,values are reported here. 
These isolated spots were then cut out, resuspended in methanol and used in a spot inhibition 
assay too test inhibitory effectiveness against 5. epidermidis. 
TLC Spot Inhibition Assay. All spots from the TLC plates were cut out and resuspended in methanol. 
A spot inhibition assay was then performed on these resuspended metabolic compounds. Four 
compounds were found to inhibit the growth of S. epidermidis. One of these compounds was isolated 
from the Hargis whole cell extract and the other three were isolated from the Jackson whole cell extract. 
The compound isolated from Hargis inhibited growth on top ofthe area of the pipet droplet and, in 
addition, showed slightly more inhibition in a faint halo around the droplet area. All three compounds 
from Jackson inhibited growth only on top of the area that the pipet droplet covered (data not shown). 
The Hargis compound may have caused more inhibition because it is smaller in size, allowing the 
molecules to diffuse more freely through the agar and therefore inhibiting a larger area of S. epidermidis 
than the metabolites isolated from Jackson. The whole cell extract from Hargis also had the largest zone 
of inhibition in the whole cell extract spot inhibition assay. 
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Discussion and Conclusions 
My research this summer has optimized methods for antimicrobial metabolite extraction and 
separation. This work contributes to the resolution of the antibiotic crisis by using old methods made 
new again to search for novel antibiotics that might be able combat the rise in antibiotic resistant 
bacterial infections. Overuse of antibiotics in humans and in food-producing animals has contributed to 
this increase in antibiotic resistant bacteria. Decreased discovery and production of new antibiotics by 
pharmaceutical companies has exacerbated the antibiotic crisis. 
A variety of soil bacteria were isolated that inhibited the growth of S. epidermidis and S. aureus, 
including the four bacteria that I worked with on this project-Bubbles, Hargis, Jackson, and Small. The 
growth inhibition assay was used to identify antibiotic producing bacteria. Metabolites were extracted 
from these bacteria and their inhibitory ability against Staphylococcus was assessed to confirm that the 
antibiotic was in the extract. The whole cell extract was then separated using thin layer chromatography 
with a methanol-chloroform mobile phase and each isolated compound was put through another 
growth inhibition assay to see which individual compounds have antimicrobial activity against 
Staphylococcus. 
Future plans for this project include further separation using 2D TLC to ensure that no spots are 
stacked on top of one another. Using an additional mobile phase with different affinities for the 
metabolites, we will be able to separate these potentially stacked metabolites. A hexane/chloroform 
mobile phase is a prospective option for these 2D TLC plates. Other future plans include using the Rt 
measurements from the TLC plates created in this research to run larger amounts of the whole cell 
metabolite extract through high performance liquid chromatography (HPLC) to get larger quantities of 
isolated antimicrobial metabolites. These large quantities of antimicrobial metabolites will be further 
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characterized using mass spectrometry and will be put on plant seeds to make sure that the compounds 
are not toxic to eukaryotic cells. 
Compounds isolated and identified in this project can be assessed for viability as new antibiotics 
for therapeutic use in humans. The ultimate goal of this project is to find new antibiotic treatments, 
which work by different mechanisms, to combat multidrug resistant pathogens and to protect these 
new treatments from misuse. We must not follow the same paths that first lead us to the antibiotic 
crisis. Antibiotics should be used only when absolutely necessary in both humans and food-producing 
animals. We must use these drugs responsibly and ethically to maintain their viability for the 
generations of the future. 
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